Brief: Gossamer Bio Inc Reports Quarterly Loss Per Share Of $0.59

Gossamer Bio

17/03/2023 11:36

March 17 (Reuters) - Gossamer Bio Inc  GOSS.O :
    * GOSSAMER BIO ANNOUNCES FOURTH QUARTER AND FULL-YEAR 2022
FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
    * CASH, CASH EQUIVALENTS AND MARKETABLE SECURITIES TOTALED
$256
MILLION AT YEAR-END 2022
    * QTRLY LOSS PER SHARE $0.59
    * GOSSAMER BIO - EXPECT CURRENT CASH, CASH EQUIVALENTS,
MARKETABLE
SECURITIES TO BE SUFFICIENT TO FUND OPERATING AND CAPEX INTO
SECOND HALF OF 2024
    * Q4 EARNINGS PER SHARE VIEW $-0.62 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nBw6R0j77a 
Further company coverage:  GOSS.O 

 ((Reuters.Briefs@thomsonreuters.com;))